Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Harvard Business School
Mallinckrodt
Colorcon

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019658

See Plans and Pricing

« Back to Dashboard

NDA 019658 describes CLARITIN HIVES RELIEF, which is a drug marketed by Bayer Healthcare Llc and is included in three NDAs. It is available from six suppliers. Additional details are available on the CLARITIN HIVES RELIEF profile page.

The generic ingredient in CLARITIN HIVES RELIEF is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and forty-five suppliers are listed for this compound. Additional details are available on the loratadine profile page.
Summary for 019658
Tradename:CLARITIN HIVES RELIEF
Applicant:Bayer Healthcare Llc
Ingredient:loratadine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019658
Suppliers and Packaging for NDA: 019658
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARITIN loratadine TABLET;ORAL 019658 NDA Bayer HealthCare LLC. 11523-1527 11523-1527-1 50 POUCH in 1 BOX (11523-1527-1) > 1 TABLET in 1 POUCH
CLARITIN loratadine TABLET;ORAL 019658 NDA Bayer HealthCare LLC. 11523-1527 11523-1527-2 50 POUCH in 1 BOX (11523-1527-2) > 1 TABLET in 1 POUCH
Paragraph IV (Patent) Challenges for 019658
Tradename Dosage Ingredient NDA Submissiondate
CLARITIN TABLET;ORAL loratadine 019658
CLARITIN HIVES RELIEF TABLET;ORAL loratadine 019658

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength10MG
Approval Date:Nov 27, 2002TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength10MG
Approval Date:Nov 19, 2003TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Boehringer Ingelheim
Medtronic
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.